Authors:
BEASLEY CM
SAYLER ME
KIESLER GM
POTVIN JH
SANGER TM
TOLLEFSON GD
Citation: Cm. Beasley et al., THE INFLUENCE OF PHARMACOTHERAPY ON SELF-DIRECTED AND EXTERNALLY-DIRECTED AGGRESSION IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 28-28
Citation: Gd. Tollefson et al., THE COURSE OF PSYCHOMOTOR AGITATION DURING PHARMACOTHERAPY OF DEPRESSION - ANALYSIS FROM DOUBLE-BLIND, CONTROLLED TRIALS, Biological psychiatry, 41, 1997, pp. 334-334
Authors:
GOLDSTEIN DJ
RAMPEY AH
ROBACK PJ
WILSON MG
HAMILTON SH
SAYLER ME
TOLLEFSON GD
Citation: Dj. Goldstein et al., EFFICACY AND SAFETY OF LONG-TERM FLUOXETINE TREATMENT OF OBESITY - MAXIMIZING SUCCESS, Obesity research, 3, 1995, pp. 481-490
Authors:
GOLDSTEIN DJ
SAYLER ME
RAMPEY AH
ROBACK PJ
Citation: Dj. Goldstein et al., FLUOXETINE THERAPY IN PATIENTS WITH OBESITY AND INSULIN-DEPENDENT DIABETES-MELLITUS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 200-200
Authors:
SAYLER ME
GOLDSTEIN DJ
ROBACK PJ
ATKINSON RL
Citation: Me. Sayler et al., EVALUATING SUCCESS OF WEIGHT-LOSS PROGRAMS, WITH AN APPLICATION TO FLUOXETINE WEIGHT-REDUCTION CLINICAL-TRIAL DATA, International journal of obesity, 18(11), 1994, pp. 742-751
Authors:
SAYLER ME
GOLDSTEIN DJ
ROBACK PJ
ATKINSON RL
Citation: Me. Sayler et al., EVALUATING SUCCESS OF WEIGHT-LOSS PROGRAMS, WITH AN APPLICATION TO FLUOXETINE WEIGHT-REDUCTION CLINICAL-TRIAL DATA, International journal of obesity, 18(11), 1994, pp. 742-751
Authors:
TOLLEFSON GD
GREIST JH
JEFFERSON JW
HEILIGENSTEIN JH
SAYLER ME
TOLLEFSON SL
KOBACK K
Citation: Gd. Tollefson et al., IS BASE-LINE AGITATION A RELATIVE CONTRAINDICATION FOR A SELECTIVE SEROTONIN REUPTAKE INHIBITOR - A COMPARATIVE TRIAL OF FLUOXETINE VERSUS IMIPRAMINE, Journal of clinical psychopharmacology, 14(6), 1994, pp. 385-391
Authors:
TOLLEFSON GD
HOLMAN SL
SAYLER ME
POTVIN JH
Citation: Gd. Tollefson et al., FLUOXETINE, PLACEBO, AND TRICYCLIC ANTIDEPRESSANTS IN MAJOR DEPRESSION WITH AND WITHOUT ANXIOUS FEATURES, The Journal of clinical psychiatry, 55(2), 1994, pp. 50-59
Citation: Ac. Pande et Me. Sayler, SEVERITY OF DEPRESSION AND RESPONSE TO FLUOXETINE, International clinical psychopharmacology, 8(4), 1993, pp. 243-245
Citation: Ac. Pande et Me. Sayler, ADVERSE EVENTS AND TREATMENT DISCONTINUATIONS IN FLUOXETINE CLINICAL-TRIALS, International clinical psychopharmacology, 8(4), 1993, pp. 267-269
Citation: Cm. Beasley et al., FLUOXETINE VERSUS AMITRIPTYLINE IN THE TREATMENT OF MAJOR DEPRESSION - A MULTICENTER TRIAL, International clinical psychopharmacology, 8(3), 1993, pp. 143-149